A detailed history of Potomac Capital Management, Inc. transactions in Biomerica Inc stock. As of the latest transaction made, Potomac Capital Management, Inc. holds 167,700 shares of BMRA stock, worth $46,956. This represents 0.37% of its overall portfolio holdings.

Number of Shares
167,700
Previous 171,519 2.23%
Holding current value
$46,956
Previous $147,000 42.18%
% of portfolio
0.37%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.71 - $1.65 $2,711 - $6,301
-3,819 Reduced 2.23%
167,700 $209,000
Q3 2023

Nov 14, 2023

SELL
$0.82 - $1.65 $189,745 - $381,805
-231,397 Reduced 57.43%
171,519 $147,000
Q2 2023

Aug 14, 2023

SELL
$1.12 - $1.87 $32,760 - $54,697
-29,250 Reduced 6.77%
402,916 $547,000
Q1 2023

May 15, 2023

BUY
$1.86 - $3.56 $803,828 - $1.54 Million
432,166 New
432,166 $808,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $3.76M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Potomac Capital Management, Inc. Portfolio

Follow Potomac Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Potomac Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Potomac Capital Management, Inc. with notifications on news.